CONMED (CNMD) Competitors $60.99 -0.32 (-0.52%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$61.22 +0.23 (+0.38%) As of 02/21/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends CNMD vs. STVN, BLCO, INSP, NARI, NVST, PRCT, IRTC, WRBY, LIVN, and ENOVShould you be buying CONMED stock or one of its competitors? The main competitors of CONMED include Stevanato Group (STVN), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), Inari Medical (NARI), Envista (NVST), PROCEPT BioRobotics (PRCT), iRhythm Technologies (IRTC), Warby Parker (WRBY), LivaNova (LIVN), and Enovis (ENOV). These companies are all part of the "medical equipment" industry. CONMED vs. Stevanato Group Bausch + Lomb Inspire Medical Systems Inari Medical Envista PROCEPT BioRobotics iRhythm Technologies Warby Parker LivaNova Enovis CONMED (NYSE:CNMD) and Stevanato Group (NYSE:STVN) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, earnings, institutional ownership, analyst recommendations, valuation, profitability, community ranking, risk and media sentiment. Is CNMD or STVN more profitable? Stevanato Group has a net margin of 10.47% compared to CONMED's net margin of 10.13%. CONMED's return on equity of 14.31% beat Stevanato Group's return on equity.Company Net Margins Return on Equity Return on Assets CONMED10.13% 14.31% 5.64% Stevanato Group 10.47%9.86%5.79% Do analysts prefer CNMD or STVN? CONMED currently has a consensus price target of $77.20, indicating a potential upside of 26.58%. Given CONMED's higher probable upside, analysts plainly believe CONMED is more favorable than Stevanato Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CONMED 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60Stevanato Group 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83 Which has better earnings & valuation, CNMD or STVN? Stevanato Group has lower revenue, but higher earnings than CONMED. CONMED is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCONMED$1.31B1.44$132.42M$4.2414.38Stevanato Group$1.17B5.34$157.62M$0.4744.06 Does the MarketBeat Community favor CNMD or STVN? CONMED received 7 more outperform votes than Stevanato Group when rated by MarketBeat users. However, 63.04% of users gave Stevanato Group an outperform vote while only 47.37% of users gave CONMED an outperform vote. CompanyUnderperformOutperformCONMEDOutperform Votes3647.37% Underperform Votes4052.63% Stevanato GroupOutperform Votes2963.04% Underperform Votes1736.96% Which has more risk & volatility, CNMD or STVN? CONMED has a beta of 1.46, indicating that its stock price is 46% more volatile than the S&P 500. Comparatively, Stevanato Group has a beta of 0.56, indicating that its stock price is 44% less volatile than the S&P 500. Does the media prefer CNMD or STVN? In the previous week, CONMED had 2 more articles in the media than Stevanato Group. MarketBeat recorded 5 mentions for CONMED and 3 mentions for Stevanato Group. Stevanato Group's average media sentiment score of 1.05 beat CONMED's score of 0.84 indicating that Stevanato Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CONMED 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Stevanato Group 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryStevanato Group beats CONMED on 9 of the 16 factors compared between the two stocks. Get CONMED News Delivered to You Automatically Sign up to receive the latest news and ratings for CNMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CNMD vs. The Competition Export to ExcelMetricCONMEDElectromedical equipment IndustryMedical SectorNYSE ExchangeMarket Cap$1.89B$3.40B$5.77B$20.07BDividend Yield1.27%1.65%4.78%3.65%P/E Ratio14.3816.9626.4634.91Price / Sales1.4474.87453.6915.64Price / Cash9.3845.9944.0420.85Price / Book1.963.867.634.92Net Income$132.42M$92.00M$3.18B$1.02B7 Day Performance-3.26%4.50%-1.91%-1.05%1 Month Performance-14.15%9.09%-0.19%-1.09%1 Year Performance-25.04%12.27%16.70%13.70% CONMED Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CNMDCONMED4.7687 of 5 stars$60.99-0.5%$77.20+26.6%-25.1%$1.89B$1.31B14.384,000STVNStevanato Group1.2431 of 5 stars€19.49+2.2%N/A-32.8%$5.90B$1.17B41.475,635BLCOBausch + Lomb3.7328 of 5 stars$16.44-1.2%$20.25+23.2%-5.3%$5.79B$4.15B-15.6513,300Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageINSPInspire Medical Systems4.8316 of 5 stars$184.73-1.3%$228.82+23.9%-4.2%$5.54B$624.80M172.651,011Insider TradeNARIInari Medical1.6761 of 5 stars$79.93flat$68.00-14.9%+40.0%$4.68B$493.63M-59.211,300NVSTEnvista3.544 of 5 stars$21.59+0.3%$20.21-6.4%-6.5%$3.71B$2.51B-3.3312,800PRCTPROCEPT BioRobotics3.2668 of 5 stars$67.61-2.4%$97.86+44.7%+28.3%$3.53B$199.84M-34.67430Positive NewsIRTCiRhythm Technologies1.1354 of 5 stars$112.11-0.1%$108.45-3.3%+6.8%$3.51B$492.68M-23.072,000Earnings ReportAnalyst ForecastNews CoverageGap UpWRBYWarby Parker2.5425 of 5 stars$25.70-2.7%$21.77-15.3%+71.6%$2.61B$669.77M-95.193,491Upcoming EarningsAnalyst ForecastLIVNLivaNova3.5803 of 5 stars$47.68+0.1%$69.17+45.1%-16.5%$2.59B$1.15B113.522,900Upcoming EarningsENOVEnovis3.4615 of 5 stars$43.89+0.4%$64.83+47.7%-29.1%$2.50B$1.71B-20.046,550Short Interest ↓Positive News Related Companies and Tools Related Companies STVN Competitors BLCO Competitors INSP Competitors NARI Competitors NVST Competitors PRCT Competitors IRTC Competitors WRBY Competitors LIVN Competitors ENOV Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:CNMD) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CONMED Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share CONMED With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CNMD Stock Alerts